Joanna Góra-Tybor

Institute of Hematology and Transfusion Medicine

Poland

Research Interests

Explore related searches

Professors in Poland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (4)

Magdalena Olszewska-Szopa

Medical University of Silesia

POLAND

View details

Victoria Empson

AOP Orphan Pharmaceuticals GmbH

AUSTRIA

View details

Karolina Chromik

Medical University of Silesia

POLAND

View details

Grzegorz Helbig

POLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Joanna Góra-Tybor

Research Interests

Explore related searches

Contact this professor

Articles (13)

Impact of treatment for adolescent and young adults with essential thrombocythemia and polycythemia vera

Characteristics and outcomes of patients with lymphoma who developed therapy-related acute myeloid leukemia or myelodysplastic syndrome – a retrospective analysis of the Polish Adult Leukemia Group

Predictors and Profile of Severe Infectious Complications in Multiple Myeloma Patients Treated with Daratumumab-Based Regimens: A Machine Learning Model for Pneumonia Risk

ROP‑ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa‑2b in essential thrombocythemia patients with limited treatment options

Real-World Outcome and Prognostic Factors in MDS Patients Treated with Azacitidine - A Retrospective Analysis

Recommendations of Polish Adult Leukemia Group concerning diagnostics and treatment of polycythemia vera

Safety considerations for drugs newly approved for treating acute myeloid leukemia

Treatment options for anaemia in myelofibrosis

Experimental drugs in clinical trials for acute myeloid leukemia: innovations, trends, and opportunities

Analysis of Predictive Factors for Early Response to Ruxolitinib in 320 Patients with Myelofibrosis From the Polish Adult Leukemia Group (PALG) Registry.

Therapy of Philadelphia-negative myeloproliferative neoplasms in the blast phase

Antifungal management in adults and children with hematological malignancies or undergoing hematopoietic cell transplantation: recommendations of Polish Society of Hematology and Blood Transfusion, Polish Society of Pediatric Oncology and Hematology, and Polish Adult Leukemia Study Group, 2020

Genetic polymorphisms associated with telomere length and risk of developing myeloproliferative neoplasms

Collaborators (4)

Magdalena Olszewska-Szopa

Victoria Empson

Karolina Chromik

Grzegorz Helbig

Make your next move.